Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions.

De Palma G, Dick FD, Calzetti S, Scott NW, Prescott GJ, Osborne A, Haites N, Mozzoni P, Negrotti A, Scaglioni A, Mutti A; Geoparkinson Study Group.

Mov Disord. 2010 May 15;25(7):912-9. doi: 10.1002/mds.22980.

PMID:
20461808
2.

Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study.

Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Soderkvist P, Felice A; Geoparkinson Study Group.

Occup Environ Med. 2007 Oct;64(10):673-80. Epub 2007 Apr 20.

3.

Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease.

Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD.

Neurosci Lett. 2004 Aug 19;366(3):326-31.

PMID:
15288444
4.
5.

GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.

Schneider J, Bernges U, Philipp M, Woitowitz HJ.

Cancer Lett. 2004 May 10;208(1):65-74.

PMID:
15105047
6.

[Biomarkers of gentotoxic risk and metabolic polymorphism].

Pavanello S, Clonfero E.

Med Lav. 2000 Sep-Oct;91(5):431-69. Review. Italian.

PMID:
11189784
7.

GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.

Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG.

Carcinogenesis. 2005 Feb;26(2):395-401. Epub 2004 Nov 4. Erratum in: Carcinogenesis. 2005 Apr;26(4):865.

PMID:
15528218
8.

GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India.

Jain M, Kumar S, Rastogi N, Lal P, Ghoshal UC, Tiwari A, Pant MC, Baiq MQ, Mittal B.

Cancer Lett. 2006 Oct 8;242(1):60-7. Epub 2005 Dec 7.

PMID:
16338071
9.

A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy.

Smargiassi A, Mutti A, De Rosa A, De Palma G, Negrotti A, Calzetti S.

Neurotoxicology. 1998 Aug-Oct;19(4-5):709-12.

PMID:
9745932
10.

Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.

Mellick GD, Buchanan DD, McCann SJ, James KM, Johnson AG, Davis DR, Liyou N, Chan D, Le Couteur DG.

Mov Disord. 1999 Mar;14(2):219-24.

PMID:
10091612
11.
12.

A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.

Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, Giles GG, Southey MC, Chenevix-Trench G, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):769-74.

13.

Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.

Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D.

Mutat Res. 2008 Feb 1;638(1-2):184-94. Epub 2007 Oct 16.

PMID:
18035380
14.

CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study.

Harhangi BS, Oostra BA, Heutink P, van Duijn CM, Hofman A, Breteler MM.

Mov Disord. 2001 Mar;16(2):290-3.

PMID:
11295783
15.

Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.

Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB.

Carcinogenesis. 2007 Jul;28(7):1455-62. Epub 2007 Feb 16.

PMID:
17307803
16.

Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study.

Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Counsell C, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Söderkvist P, Felice A; Geoparkinson study group.

Occup Environ Med. 2007 Oct;64(10):666-72. Epub 2007 Mar 1.

17.

Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.

Matthias C, Bockmühl U, Jahnke V, Jones PW, Hayes JD, Alldersea J, Gilford J, Bailey L, Bath J, Worrall SF, Hand P, Fryer AA, Strange RC.

Pharmacogenetics. 1998 Apr;8(2):91-100.

PMID:
10022746
18.

Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population.

Honma HN, De Capitani EM, Perroud MW Jr, Barbeiro AS, Toro IF, Costa DB, Lima CS, Zambon L.

Lung Cancer. 2008 Aug;61(2):152-62. doi: 10.1016/j.lungcan.2007.12.014. Epub 2008 Feb 14.

PMID:
18280004
19.

Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India.

Pandey SN, Jain M, Nigam P, Choudhuri G, Mittal B.

Biomarkers. 2006 May-Jun;11(3):250-61.

PMID:
16760134
20.

Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.

Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, Madhavan J, Ankathil R.

J Exp Ther Oncol. 2008;7(1):73-85.

PMID:
18472644

Supplemental Content

Support Center